Revenue (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
|---|
| Revenue from Contract with Customer [Abstract] |
|
| Schedule of Disaggregation of Revenue |
Net revenue for the periods presented represents sales of Amtagvi® and Proleukin® as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Amtagvi® |
|
$ |
|
101,602 |
|
|
$ |
|
57,482 |
|
|
$ |
|
252,545 |
|
|
$ |
|
155,127 |
|
Proleukin® |
|
|
|
19,867 |
|
|
|
|
9,973 |
|
|
|
|
39,667 |
|
|
|
|
21,604 |
|
Total net revenue |
|
$ |
|
121,469 |
|
|
$ |
|
67,455 |
|
|
$ |
|
292,212 |
|
|
$ |
|
176,731 |
|
Consolidated net product revenue by geographic area for the periods presented is as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
United States |
|
$ |
|
120,004 |
|
|
$ |
|
66,402 |
|
|
$ |
|
289,443 |
|
|
$ |
|
173,527 |
|
Rest of world |
|
|
|
1,465 |
|
|
|
|
1,053 |
|
|
|
|
2,769 |
|
|
|
|
3,204 |
|
Net revenue |
|
$ |
|
121,469 |
|
|
$ |
|
67,455 |
|
|
$ |
|
292,212 |
|
|
$ |
|
176,731 |
|
|
| Schedule of GTN Adjustments Recorded in Revenue |
Revenue from product sales was recorded net of GTN adjustments. The following table summarizes GTN adjustments for the periods presented (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Gross revenue |
|
$ |
|
122,488 |
|
|
$ |
|
68,521 |
|
|
$ |
|
295,694 |
|
|
$ |
|
179,040 |
|
GTN adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government rebates and chargebacks |
|
|
|
(4 |
) |
|
|
|
(58 |
) |
|
|
|
(307 |
) |
|
|
|
(355 |
) |
Wholesaler fees and cash discounts |
|
|
|
(1,336 |
) |
|
|
|
(741 |
) |
|
|
|
(2,908 |
) |
|
|
|
(1,528 |
) |
Other rebates, returns, discounts and adjustments |
|
|
|
321 |
|
|
|
|
(267 |
) |
|
|
|
(267 |
) |
|
|
|
(426 |
) |
Total GTN adjustments |
|
|
|
(1,019 |
) |
|
|
|
(1,066 |
) |
|
|
|
(3,482 |
) |
|
|
|
(2,309 |
) |
Net revenue |
|
$ |
|
121,469 |
|
|
$ |
|
67,455 |
|
|
$ |
|
292,212 |
|
|
$ |
|
176,731 |
|
|
| Schedule of Amount and Percentage of Gross Revenue Concentration |
The following table summarizes the amount and percentage of gross revenue attributable to customers that represented more than 10% of the Company’s gross revenue and all other customers as a group for the three and nine months ended September 30, 2026 and 2025, respectively (in thousands, except percentages):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, 2026 |
|
|
September 30, 2026 |
|
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
Customer A |
|
$ |
* |
|
|
|
0 |
% |
|
$ |
* |
|
|
|
0 |
% |
Other customers |
|
|
|
122,488 |
|
|
|
100 |
% |
|
|
|
295,694 |
|
|
|
100 |
% |
Gross revenue |
|
$ |
|
122,488 |
|
|
|
100 |
% |
|
$ |
|
295,694 |
|
|
|
100 |
% |
GTN adjustments |
|
|
|
(1,019 |
) |
|
|
|
|
|
|
(3,482 |
) |
|
|
|
Net revenue |
|
$ |
|
121,469 |
|
|
|
|
|
$ |
|
292,212 |
|
|
|
|
* Represents customer below 10% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, 2025 |
|
|
September 30, 2025 |
|
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
Customer A |
|
$ |
* |
|
|
|
0 |
% |
|
$ |
* |
|
|
|
0 |
% |
Other customers |
|
|
|
68,521 |
|
|
|
100 |
% |
|
|
|
179,040 |
|
|
|
100 |
% |
Gross revenue |
|
$ |
|
68,521 |
|
|
|
100 |
% |
|
$ |
|
179,040 |
|
|
|
100 |
% |
GTN adjustments |
|
|
|
(1,066 |
) |
|
|
|
|
|
|
(2,309 |
) |
|
|
|
Net revenue |
|
$ |
|
67,455 |
|
|
|
|
|
$ |
|
176,731 |
|
|
|
|
* Represents customer below 10% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|